Association of coronary angiographic lesions and mortality in patients over 80 years with NSTEMI

Anwar J Siddiqui1,2, Elmir Omerovic3, Martin J Holzmann4

  • 1Department of Medicine, Karolinska Institutet, Stockholm, Sweden anwar.siddiqui@regionstockholm.se.

Open Heart
|February 1, 2022
PubMed

Insights

Elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI) and coronary lesions face higher mortality. Percutaneous coronary intervention (PCI) improves survival, especially for multi-vessel disease (MVD).

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Non-ST-segment elevation myocardial infarction (NSTEMI) management is critical in elderly patients.
  • Coronary artery lesions significantly impact outcomes in this demographic.

Purpose of the Study:

  • To investigate the association between coronary artery lesions and mortality in patients over 80 with NSTEMI.
  • To evaluate the impact of percutaneous coronary intervention (PCI) on survival in this patient group.

Main Methods:

  • Retrospective analysis of 5,770 patients (>80 years) with NSTEMI undergoing coronary angiography (CA) and PCI.
  • Categorization of coronary lesions into one-vessel disease (1VD), multi-vessel disease (MVD), and left main disease (LMD).
  • Cox regression analysis to determine hazard ratios (HR) for all-cause mortality associated with lesions and PCI outcomes.

Main Results:

  • Mortality was higher with 1VD (HR 1.8), MVD (HR 2.2), and LMD (HR 2.8) compared to controls.
  • PCI was associated with improved survival (HR 0.85).
  • MVD patients receiving PCI had lower mortality (HR 0.71) than those without PCI. Left main disease (LMD) showed increased complications and mortality during CA and PCI.

Conclusions:

  • Coronary lesions (>50% stenosis) are significant predictors of mortality in elderly NSTEMI patients.
  • Multi-vessel disease (MVD) is prevalent, and PCI treatment is linked to enhanced survival.
  • PCI offers a survival benefit for elderly NSTEMI patients with coronary artery disease.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
105
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
69
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
56
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
56
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
51